Eli Lilly and Company (NYSE: LLY) has announced a substantial $1 billion investment to expand its Limerick, Ireland, manufacturing site, which will increase the production of biologic active ingredients, including those for its newly approved treatment for early symptomatic Alzheimer’s disease. Simultaneously, the company unveiled a new $800 million facility expansion in Kinsale, Ireland, which […]
Merck has embarked on a monumental investment venture, injecting more than €300 million into the construction of a new Bioprocessing Production Center located in Daejeon, South Korea. This initiative stands as the most significant investment by Merck’s Life Science business sector in the Asia-Pacific region to date, underscoring the company’s dedication to expanding its operations […]
Olon, a prominent developer and manufacturer of active pharmaceutical ingredients (API) based in Italy, has strategically expanded its global operations with the acquisition of a generics chemical operations API manufacturing plant located in Mahad, Maharashtra, India. This move is part of Olon’s ambitious strategy to accelerate growth by incorporating new Contract Development and Manufacturing Organization […]
